Trial Profile
A Study to Evaluate the Perioperative Use of Dexmedetomidine in Pediatric Patients With Congenital Heart Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Adverse reactions; Therapeutic Use
- 20 May 2016 New trial record
- 10 May 2016 Primary endpoint has been met. (In-hospital mortality), as per results published in the Anesthesia and Analgesia.
- 10 May 2016 Results published in the Anesthesia and Analgesia